EPS Diluted (Quarterly) Chart

Historical EPS Diluted (Quarterly) Data

View and export this data back to 2015. Start Trial.
Date Value
September 30, 2026 -1.005
June 30, 2026 -1.458
March 31, 2026 -4.056
December 31, 2025 -12.29
September 30, 2025 -4.661
June 30, 2025 -7.004
March 31, 2025 -0.2351
December 31, 2024 -10.01
September 30, 2024 -0.318
June 30, 2024 -0.2523
March 31, 2024 -0.312
December 31, 2023 -0.4695
September 30, 2023 -0.2037
June 30, 2023 -0.3066
March 31, 2023 -0.1952
December 31, 2022 -0.7095
September 30, 2022 -0.0434
June 30, 2022 -0.0827
March 31, 2022 0.3375
December 31, 2021 0.2497
September 30, 2021 0.3831
June 30, 2021 0.329
Date Value
March 31, 2021 0.2633
December 31, 2020 0.4485
September 30, 2020 0.5315
June 30, 2020 0.5147
March 31, 2020 -0.0467
December 31, 2019 -0.10
September 30, 2019 -0.1009
June 30, 2019 -0.079
March 31, 2019 -0.0852
December 31, 2018 -0.152
September 30, 2018 -0.1328
June 30, 2018 -0.11
March 31, 2018 -0.11
December 31, 2017 -0.1222
September 30, 2017 -0.33
June 30, 2017 -2.70
March 31, 2017 -0.5207
December 31, 2016 -0.3876
September 30, 2016 -0.332
June 30, 2016 -0.3266
March 31, 2016 -0.3769
December 31, 2015 -0.3577

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
Fractyl Health, Inc. -1.068
Spectral AI, Inc. -0.1136
Omnicell, Inc. 0.2377
Oncolytics Biotech, Inc. -0.0759
Sangamo Therapeutics, Inc. -0.0796